相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Phase II Study of Ibrutinib in Advanced Neuroendocrine Neoplasms
Taymeyah Al-Toubah et al.
NEUROENDOCRINOLOGY (2020)
Nonconventional Doses of Somatostatin Analogs in Patients With Progressing Well-Differentiated Neuroendocrine Tumor
Giuseppe Lamberti et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Neuroendocrine Tumors: Results From the Phase II KEYNOTE-158 Study
Jonathan Strosberg et al.
CLINICAL CANCER RESEARCH (2020)
Pancreatic Neuroendocrine Neoplasms Landscape and Horizon
Laura H. Tang
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2020)
c-MET inhibition: novel treatment for sporadic and MEN1-associated GEP NETs
Maya Elena Lee et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2020)
Multicenter phase 2 trial of nintedanib in advanced nonpancreatic neuroendocrine tumors
Renuka Iyer et al.
CANCER (2020)
Gastric neuroendocrine tumours from long-term proton pump inhibitor users are indolent tumours with good prognosis
Vincent Q-H Trinh et al.
HISTOPATHOLOGY (2020)
Pancreatic Neuroendocrine Neoplasm Associated with a Familial MAX Deletion
Sandrine Petignot et al.
HORMONE AND METABOLIC RESEARCH (2020)
New insights into the classification of gastric neuroendocrine tumours, expanding the spectrum of ECL-cell tumours related to hypergastrinaemia
Stefano La Rosa et al.
HISTOPATHOLOGY (2020)
Surufatinib in Advanced Well-Differentiated Neuroendocrine Tumors: A Multicenter, Single-Arm, Open-Label, Phase Ib/II Trial
Jianming Xu et al.
CLINICAL CANCER RESEARCH (2019)
Targeted next-generation sequencing of well-differentiated rectal, gastric, and appendiceal neuroendocrine tumors to identify potential targets
Ha Young Park et al.
HUMAN PATHOLOGY (2019)
Precision medicine in neuroendocrine neoplasms: an update on current management and future perspectives
Germano Gaudenzi et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2019)
Final results of the TALENT trial (GETNE1509): a prospective multicohort phase II study of lenvatinib in patients (pts) with G1/G2 advanced pancreatic (panNETs) and gastrointestinal (giNETs) neuroendocrine tumors (NETs).
Jaume Capdevila et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
The landscape of molecular alterations in pancreatic and small intestinal neuroendocrine tumours
Aldo Scarpa
ANNALES D ENDOCRINOLOGIE (2019)
Everolimus as adjunctive therapy for tuberous sclerosis complex-associated partial-onset seizures
Lorena Lechuga et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2019)
Treatment Options for Pancreatic Neuroendocrine Tumors
Amit Akirov et al.
CANCERS (2019)
A phase 2 study of an oral mTORC1/mTORC2 kinase inhibitor (CC-223) for non-pancreatic neuroendocrine tumors with or without carcinoid symptoms
Edward Wolin et al.
PLOS ONE (2019)
Effects of low-dose aspirin on clinical outcome and disease progression in patients with gastroenteropancreatic neuroendocrine neoplasm
Federica Cavalcoli et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2019)
Management of Small Bowel Neuroendocrine Tumors
Vincent Larouche et al.
CANCERS (2019)
Pancreatic Neuroendocrine Tumor in a Young Child With Tuberous Sclerosis Complex 1
Shilpa Mehta et al.
JOURNAL OF THE ENDOCRINE SOCIETY (2019)
Co-occurrence of breast cancer and neuroendocrine tumours: New genetic insights beyond Multiple Endocrine Neoplasia syndromes
Vincent Larouche et al.
ENDOCRINOLOGY DIABETES & METABOLISM (2019)
Finding a cure for tuberous sclerosis complex: From genetics through to targeted drug therapies
Lauren J. McEneaney et al.
ADVANCES IN GENETICS, VOL 103 (2019)
Phase II Study of BEZ235 versus Everolimus in Patients with Mammalian Target of Rapamycin Inhibitor-Naive Advanced Pancreatic Neuroendocrine Tumors
Ramon Salazar et al.
ONCOLOGIST (2018)
Targeted therapy of gastroenteropancreatic neuroendocrine tumours: preclinical strategies and future targets
E. T. Aristizabal Prada et al.
ENDOCRINE CONNECTIONS (2018)
Loss of Chromatin-Remodeling Proteins and/or CDKN2A Associates With Metastasis of Pancreatic Neuroendocrine Tumors and Reduced Patient Survival Times
Somak Roy et al.
GASTROENTEROLOGY (2018)
Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues
Sara Pusceddu et al.
GASTROENTEROLOGY (2018)
Pancreatic neuroendocrine carcinomas reveal a closer relationship to ductal adenocarcinomas than to neuroendocrine tumors G3
Bjoern Konukiewitz et al.
HUMAN PATHOLOGY (2018)
Genomic profile of appendiceal goblet cell carcinoid is distinct compared to appendiceal neuroendocrine tumor and conventional adenocarcinoma
Kwun Wah Wen et al.
HUMAN PATHOLOGY (2018)
Genomic landscape of pancreatic neuroendocrine tumours: the International Cancer Genome Consortium
Andrea Mafficini et al.
JOURNAL OF ENDOCRINOLOGY (2018)
A Comprehensive Assessment of the Role of miRNAs as Biomarkers in Gastroenteropancreatic Neuroendocrine Tumors
Anna Malczewska et al.
NEUROENDOCRINOLOGY (2018)
Endocrine pathology: past, present and future
Sylvia L. Asa et al.
PATHOLOGY (2018)
MAFA missense mutation causes familial insulinomatosis and diabetes mellitus
Donato Iacovazzo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Diagnosis, Pathological Findings, and Clinical Management of Gangliocytic Paraganglioma: A Systematic Review
Yoichiro Okubo et al.
FRONTIERS IN ONCOLOGY (2018)
1308OActivity & safety of spartalizumab (PDR001) in patients (pts) with advanced neuroendocrine tumors (NET) of pancreatic (Pan), gastrointestinal (GI), or thoracic (T) origin, & gastroenteropancreatic neuroendocrine carcinoma (GEP NEC) who have progressed on prior treatment (Tx)
J C Yao et al.
ANNALS OF ONCOLOGY (2018)
Sunitinib in pancreatic neuroendocrine tumors: updated progression-free survival and final overall survival from a phase III randomized study
S. Faivre et al.
ANNALS OF ONCOLOGY (2017)
Alternative Lengthening of Telomeres in Primary Pancreatic Neuroendocrine Tumors Is Associated with Aggressive Clinical Behavior and Poor Survival
Joo Young Kim et al.
CLINICAL CANCER RESEARCH (2017)
Alternative Lengthening of Telomeres and Loss of DAXX/ATRX Expression Predicts Metastatic Disease and Poor Survival in Patients with Pancreatic Neuroendocrine Tumors
Aatur D. Singhi et al.
CLINICAL CANCER RESEARCH (2017)
Four Neuroendocrine Tumor Types and Neuroendocrine Carcinoma of the Duodenum: Analysis of 203 Cases
Alessandro Vanoli et al.
NEUROENDOCRINOLOGY (2017)
A MUTYH germline mutation is associated with small intestinal neuroendocrine tumors
Jan P. Dumanski et al.
ENDOCRINE-RELATED CANCER (2017)
The future: genetics advances in MEN1 therapeutic approaches and management strategies
Sunita K. Agarwal
ENDOCRINE-RELATED CANCER (2017)
Corticotroph Pituitary Carcinoma in a Patient With Lynch Syndrome (LS) and Pituitary Tumors in a Nationwide LS Cohort
Daniel Bengtsson et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
Phase II trial of cabozantinib in patients with carcinoid and pancreatic neuroendocrine tumors (pNET).
Jennifer A. Chan et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Phase III Prospective Randomized Comparison Trial of Depot Octreotide Plus Interferon Alfa-2b Versus Depot Octreotide Plus Bevacizumab in Patients With Advanced Carcinoid Tumors: SWOG S0518
James C. Yao et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Somatostatin receptor expression related to TP53 and RB1 alterations in pancreatic and extrapancreatic neuroendocrine neoplasms with a Ki67-index above 20%
Bjoern Konukiewitz et al.
MODERN PATHOLOGY (2017)
HIF1A and EPAS1 potentiate hypoxia-induced upregulation of inhibin alpha chain expression in human term cytotrophoblasts in vitro
C. L. Depoix et al.
MOLECULAR HUMAN REPRODUCTION (2017)
Whole-genome landscape of pancreatic neuroendocrine tumours
Aldo Scarpa et al.
NATURE (2017)
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Systemic Therapy - Chemotherapy
Rocio Garcia-Carbonero et al.
NEUROENDOCRINOLOGY (2017)
Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors
J. Strosberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Evolving role of the endoscopist in management of gastrointestinal neuroendocrine tumors
Cemal Yazici et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
DAXX/ATRX and MEN1 genes are strong prognostic markers in pancreatic neuroendocrine tumors
Joo Kyung Park et al.
ONCOTARGET (2017)
Antiproliferative effect of somatostatin analogs in advanced gastro-entero-pancreatic neuroendocrine tumors: a systematic review and meta-analysis
Elettra Merola et al.
ONCOTARGET (2017)
Pancreatic non-functioning neuroendocrine tumor: a new entity genetically related to Lynch syndrome
Anna Serracant Barrera et al.
JOURNAL OF GASTROINTESTINAL ONCOLOGY (2017)
Rb Loss and KRAS Mutation Are Predictors of the Response to Platinum-Based Chemotherapy in Pancreatic Neuroendocrine Neoplasm with Grade 3: A Japanese Multicenter Pancreatic NEN-G3 Study
Susumu Hijioka et al.
CLINICAL CANCER RESEARCH (2017)
Mafa Enables Pdx1 to Effectively Convert Pancreatic Islet Progenitors and Committed Islet -Cells Into -Cells In Vivo
Taka-aki Matsuoka et al.
DIABETES (2017)
Prognostic Impact of Novel Molecular Subtypes of Small Intestinal Neuroendocrine Tumor
Anna Karpathakis et al.
CLINICAL CANCER RESEARCH (2016)
Cytomorphology of neuroendocrine tumours of the gallbladder
R. Yadav et al.
CYTOPATHOLOGY (2016)
Cytotoxic Effects of Valproic Acid on Neuroendocrine Tumour Cells
Yvonne Arvidsson et al.
NEUROENDOCRINOLOGY (2016)
A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas
Laura H. Tang et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2016)
Diagnosis and management of gastrointestinal neuroendocrine tumors: An evidence-based Canadian consensus
Simron Singh et al.
CANCER TREATMENT REVIEWS (2016)
HIF2A gain-of-function mutations detected in duodenal gangliocytic paraganglioma
Zhengping Zhuang et al.
ENDOCRINE-RELATED CANCER (2016)
A phase II study of axitinib in advanced neuroendocrine tumors
J. R. Strosberg et al.
ENDOCRINE-RELATED CANCER (2016)
Everolimus for the Treatment of Advanced Pancreatic Neuroendocrine Tumors: Overall Survival and Circulating Biomarkers From the Randomized, Phase III RADIANT-3 Study
James C. Yao et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study
James C. Yao et al.
LANCET (2016)
ENETS Consensus Guidelines Update for Gastroduodenal Neuroendocrine Neoplasms
G. Delle Fave et al.
NEUROENDOCRINOLOGY (2016)
The Impact of PD-L1 Expression in Patients with Metastatic GEP-NETs
Seung Tae Kim et al.
JOURNAL OF CANCER (2016)
Identification of immunotherapeutic targets by genomic profiling of rectal NET metastases
Zeynep Kosaloglu et al.
ONCOIMMUNOLOGY (2016)
A Delphic consensus assessment: imaging and biomarkers in gastroenteropancreatic neuroendocrine tumor disease management
Kjell Oberg et al.
ENDOCRINE CONNECTIONS (2016)
Pazopanib in pretreated advanced neuroendocrine tumors: a phase II, open-label trial of the Spanish Task Force Group for Neuroendocrine Tumors (GETNE)aEuro
E. Grande et al.
ANNALS OF ONCOLOGY (2015)
Phase I study of the anti-IGF1R antibody cixutumumab with everolimus and octreotide in advanced well- differentiated neuroendocrine tumors
Arvind Dasari et al.
ENDOCRINE-RELATED CANCER (2015)
Exome sequencing identifies ATP4A gene as responsible of an atypical familial type I gastric neuroendocrine tumour
Oriol Calvete et al.
HUMAN MOLECULAR GENETICS (2015)
Molecular characteristics of colorectal neuroendocrine carcinoma; similarities with adenocarcinoma rather than neuroendocrine tumor
Nobuyoshi Takizawa et al.
HUMAN PATHOLOGY (2015)
Circulating Transcript Analysis (NETest) in GEP-NETs Treated With Somatostatin Analogs Defines Therapy
Jaroslaw B. Cwikla et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Glucagon Cell Hyperplasia and Neoplasia With and Without Glucagon Receptor Mutations
Bence Sipos et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Telotristat Etiprate for Carcinoid Syndrome: A Single-Arm, Multicenter Trial
Marianne Pavel et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Multicenter Phase II Trial of Temsirolimus and Bevacizumab in Pancreatic Neuroendocrine Tumors
Timothy J. Hobday et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Pazopanib and depot octreotide in advanced, well-differentiated neuroendocrine tumours: a multicentre, single-group, phase 2 study
Alexandria T. Phan et al.
LANCET ONCOLOGY (2015)
High Expression of MicroRNA-196a Indicates Poor Prognosis in Resected Pancreatic Neuroendocrine Tumor
Yoon Suk Lee et al.
MEDICINE (2015)
Epigenetic Regulation of the lncRNA MEG3 and Its Target c-MET in Pancreatic Neuroendocrine Tumors
Sita D. Modali et al.
MOLECULAR ENDOCRINOLOGY (2015)
Pathology, genetics and precursors of human and experimental pancreatic neoplasms: An update
Irene Esposito et al.
PANCREATOLOGY (2015)
DNA methylation profiles distinguish different subtypes of gastroenteropancreatic neuroendocrine tumors
Alexandre How-Kit et al.
EPIGENOMICS (2015)
Phase III study of pasireotide long-acting release in patients with metastatic neuroendocrine tumors and carcinoid symptoms refractory to available somatostatin analogues
Edward M. Wolin et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2015)
Analysis of the molecular features of rectal carcinoid tumors to identify new biomarkers that predict biological malignancy
Kei Mitsuhashi et al.
ONCOTARGET (2015)
Genetics of pancreatic neuroendocrine tumors: implications for the clinic
Antonio Pea et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2015)
Neurotensin, a novel target of Wnt/β-catenin pathway, promotes growth of neuroendocrine tumor cells
Ji Tae Kim et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Dynamic Epigenetic Regulation by Menin During Pancreatic Islet Tumor Formation
Wenchu Lin et al.
MOLECULAR CANCER RESEARCH (2015)
Somatostatin Analogs Treated Small Intestinal Neuroendocrine Tumor Patients Circulating MicroRNAs
Su-Chen Li et al.
PLOS ONE (2015)
Bevacizumab plus octreotide and metronomic capecitabine in patients with metastatic well-to-moderately differentiated neuroendocrine tumors: the xelbevoct study
Alfredo Berruti et al.
BMC CANCER (2014)
Therapeutic targeting of the mTOR-signalling pathway in cancer: benefits and limitations
M. Moschetta et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Thiocoraline activates the Notch pathway in carcinoids and reduces tumor progression in vivo
T. P. Wyche et al.
CANCER GENE THERAPY (2014)
Current concepts in the diagnosis and management of type 1 gastric neuroendocrine neoplasms
Gregory Kaltsas et al.
CLINICAL ENDOCRINOLOGY (2014)
Neuroendocrine Pathology of the Stomach: The Parma Contribution
Cesare Bordi
ENDOCRINE PATHOLOGY (2014)
Hyperplasia to Neoplasia Sequence of Duodenal and Pancreatic Neuroendocrine Diseases and Pseudohyperplasia of the PP-cells in the Pancreas
Gunter Kloeppel et al.
ENDOCRINE PATHOLOGY (2014)
TCEB3C a putative tumor suppressor gene of small intestinal neuroendocrine tumors
Katarina Edfeldt et al.
ENDOCRINE-RELATED CANCER (2014)
Bevacizumab combined with 5-FU/streptozocin in patients with progressive metastatic well-differentiated pancreatic endocrine tumours (BETTER trial) - A phase II non-randomised trial
Michel Ducreux et al.
EUROPEAN JOURNAL OF CANCER (2014)
Bevacizumab plus capecitabine in patients with progressive advanced well-differentiated neuroendocrine tumors of the gastro-intestinal (GI-NETs) tract (BETTER trial) - A phase II non-randomised trial
Emmanuel Mitry et al.
EUROPEAN JOURNAL OF CANCER (2014)
Loss of DAXX and ATRX Are Associated With Chromosome Instability and Reduced Survival of Patients With Pancreatic Neuroendocrine Tumors
Ilaria Marinoni et al.
GASTROENTEROLOGY (2014)
Gastric neuroendocrine neoplasms and related precursor lesions
Stefano La Rosa et al.
JOURNAL OF CLINICAL PATHOLOGY (2014)
Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors
Martyn E. Caplin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): The NORDIC NEC study
H. Sorbye et al.
ANNALS OF ONCOLOGY (2013)
Phase II study of pazopanib monotherapy in metastatic gastroenteropancreatic neuroendocrine tumours
H. K. Ahn et al.
BRITISH JOURNAL OF CANCER (2013)
Phase I study of sorafenib in combination with everolimus (RAD001) in patients with advanced neuroendocrine tumors
Jennifer A. Chan et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
Sorafenib and bevacizumab combination targeted therapy in advanced neuroendocrine tumour: A phase II study of Spanish Neuroendocrine Tumour Group (GETNE0801)
Daniel Castellano et al.
EUROPEAN JOURNAL OF CANCER (2013)
Somatostatin receptors: From signaling to clinical practice
Marily Theodoropoulou et al.
FRONTIERS IN NEUROENDOCRINOLOGY (2013)
Potent antitumor activity of the novel HSP90 inhibitors AUY922 and HSP990 in neuroendocrine carcinoid cells
Kathrin Zitzmann et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
The genomic landscape of small intestine neuroendocrine tumors
Michaela S. Banck et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
New Syndrome of Paraganglioma and Somatostatinoma Associated With Polycythemia
Karel Pacak et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Global microRNA profiling of well-differentiated small intestinal neuroendocrine tumors
Su-Chen Li et al.
MODERN PATHOLOGY (2013)
Somatic mutation of CDKN1B in small intestine neuroendocrine tumors
Joshua M. Francis et al.
NATURE GENETICS (2013)
Epigenetic Aspects on Therapy Development for Gastroenteropancreatic Neuroendocrine Tumors
Catharina Larsson
NEUROENDOCRINOLOGY (2013)
Precursor lesions of endocrine system neoplasms
Ozgur Mete et al.
PATHOLOGY (2013)
Gastrin: A Distinct Fate of Neurogenin3 Positive Progenitor Cells in the Embryonic Pancreas
Yaron Suissa et al.
PLOS ONE (2013)
Inhibin-expressing clear cell neuroendocrine tumor of the ampulla: an unusual presentation of von Hippel-Lindau disease
Hasan Gucer et al.
VIRCHOWS ARCHIV (2013)
Tenascin-C Downregulates Wnt Inhibitor Dickkopf-1, Promoting Tumorigenesis in a Neuroendocrine Tumor Model
Falk Saupe et al.
CELL REPORTS (2013)
Small Cell and Large Cell Neuroendocrine Carcinomas of the Pancreas are Genetically Similar and Distinct From Well-differentiated Pancreatic Neuroendocrine Tumors
Shinichi Yachida et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2012)
A phase 2 study of the insulin-like growth factor-1 receptor inhibitor MK-0646 in patients with metastatic, well-differentiated neuroendocrine tumors
Diane L. Reidy-Lagunes et al.
CANCER (2012)
The FGFR4-G388R Single-Nucleotide Polymorphism Alters Pancreatic Neuroendocrine Tumor Progression and Response to mTOR Inhibition Therapy
Stefano Serra et al.
CANCER RESEARCH (2012)
Molecular Profiling of Pancreatic Neuroendocrine Tumors in Sporadic and Von Hippel-Lindau Patients
Daniela Speisky et al.
CLINICAL CANCER RESEARCH (2012)
Pancreatic neuroendocrine tumors in patients with tuberous sclerosis complex
A. M. Larson et al.
CLINICAL GENETICS (2012)
Functional characterization of a rare germline mutation in the gene encoding the cyclin-dependent kinase inhibitor p27Kip1 (CDKN1B) in a Spanish patient with multiple endocrine neoplasia-like phenotype
Donatella Malanga et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2012)
Unusual DNA mismatch repair-deficient tumors in Lynch syndrome: a report of new cases and review of the literature
Yevgeniy Karamurzin et al.
HUMAN PATHOLOGY (2012)
Heat shock protein 90 is a promising target for effective growth inhibition of gastrointestinal neuroendocrine tumors
Christoph Gloesenkamp et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2012)
Prospective Study of Bevacizumab Plus Temozolomide in Patients With Advanced Neuroendocrine Tumors
Jennifer A. Chan et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Loss of ATRX or DAXX expression and concomitant acquisition of the alternative lengthening of telomeres phenotype are late events in a small subset of MEN-1 syndrome pancreatic neuroendocrine tumors
Roeland F. de Wilde et al.
MODERN PATHOLOGY (2012)
Somatic HIF2A Gain-of-Function Mutations in Paraganglioma with Polycythemia
Zhengping Zhuang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
FDA Approval Summary: Sunitinib for the Treatment of Progressive Well-Differentiated Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors
Gideon M. Blumenthal et al.
ONCOLOGIST (2012)
von Hippel-Lindau disease-associated solid microcystic serous adenomas masquerading as pancreatic neuroendocrine neoplasms
Simon Turcotte et al.
SURGERY (2012)
Surgical resection of hepatic metastases from neuroendocrine neoplasms: A systematic review
Akshat Saxena et al.
SURGICAL ONCOLOGY-OXFORD (2012)
Common Pathogenetic Mechanism Involving Human Chromosome 18 in Familial and Sporadic Ileal Carcinoid Tumors
Janet L. Cunningham et al.
GENES CHROMOSOMES & CANCER (2011)
Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors.
Eric Raymond et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Everolimus for Advanced Pancreatic Neuroendocrine Tumors.
James C. Yao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
A Preclinical and Clinical Study of Lithium in Low-Grade Neuroendocrine Tumors
Sam J. Lubner et al.
ONCOLOGIST (2011)
Altered Telomeres in Tumors with ATRX and DAXX Mutations
Christopher M. Heaphy et al.
SCIENCE (2011)
DAXX/ATRX, MEN1, and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors
Yuchen Jiao et al.
SCIENCE (2011)
Modeling Pharmacological Inhibition of Mast Cell Degranulation as a Therapy for Insulinoma
Laura Soucek et al.
NEOPLASIA (2011)
Somatostatin receptor biology in neuroendocrine and pituitary tumours: part 2-clinical implications
Mehtap Cakir et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2010)
Pancreatic Endocrine Tumors: Expression Profiling Evidences a Role for AKT-mTOR Pathway
Edoardo Missiaglia et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
MicroRNA expression in ileal carcinoid tumors: downregulation of microRNA-133a with tumor progression
Katharina Ruebel et al.
MODERN PATHOLOGY (2010)
Insulinomatosis A Multicentric Insulinoma Disease that Frequently Causes Early Recurrent Hyperinsulinemic Hypoglycemia
Martin Anlauf et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2009)
High-resolution genomic profiling reveals gain of chromosome 14 as a predictor of poor outcome in ileal carcinoids
Ellinor Andersson et al.
ENDOCRINE-RELATED CANCER (2009)
Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
Anja Rinke et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Homozygous P86S Mutation of the Human Glucagon Receptor Is Associated With Hyperglucagonemia, α Cell Hyperplasia, and Islet Cell Tumor
Cuiqi Zhou et al.
PANCREAS (2009)
Is Serous Cystadenoma of the Pancreas a Model of Clear-Cell-Associated Angiogenesis and Tumorigenesis?
Duangpen Thirabanjasak et al.
PANCREATOLOGY (2009)
Inherited pancreatic endocrine tumor syndromes: Advances in molecular pathogenesis, diagnosis, management, and controversies
Robert I. Jensen et al.
CANCER (2008)
Efficacy of RAD001 (everolimus) and octreotide LAR in advanced low- to intermediate-grade neuroendocrine tumors: Results of a phase II study
James C. Yao et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Cystic pancreatic endocrine neoplasms: A distinct tumor type?
Liliana Bordelanou et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2008)
Nesidioblastosis and hyperplasia of α cells, microglucagonoma, and nonfunctioning islet cell tumor of the pancreas -: Review of the literature
Run Yu et al.
PANCREAS (2008)
Carcinoid tumor of the common bile duct: A rare complication of von Hippel-Lindau syndrome
Otmane Nafidi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Hypomethylation of LINE-1 and Alu in well-differentiated neuroendocrine tumors (pancreatic endocrine tumors and carcinoid tumors)
In-Seon Choi et al.
MODERN PATHOLOGY (2007)
Neuro-fibromatosis 1 and neuro-fibromatosis 2: a twenty first century perspective
Rosalie E. Ferner
LANCET NEUROLOGY (2007)
Association of DNA methylation and epigenetic inactivation of RASSF1A and beta-catenin with metastasis in small bowel carcinoid tumors
He-Yu Zhang et al.
ENDOCRINE (2006)
Antiproliferative and proapoptotic effects of histone deacetylase inhibitors on gastrointestinal neuroendocrine tumor cells
Viola Baradari et al.
ENDOCRINE-RELATED CANCER (2006)
Predictive factors of efficacy of the somatostatin analogue octreotide as first line therapy for advanced pancreatic endocrine carcinoma
G. Butturini et al.
ENDOCRINE-RELATED CANCER (2006)
MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior
Claudia Roldo et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
The tuberous sclerosis complex
Peter B. Crino et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Microadenomatosis of the endocrine pancreas in patients with and without the multiple endocrine neoplasia type 1 syndrome
M Anlauf et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2006)
Lipid-rich variant of pancreatic endocrine neoplasms
R Singh et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2006)
Efficacy and tolerability of pegylated IFN-alpha in patients with neuroendocrine gastroenteropancreatic carcinomas
ME Pavel et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2006)
Molecular parameters associated with insulinoma progression: chromosomal instability versus p53 and CK19 status
Y. M. H. Jonkers et al.
CYTOGENETIC AND GENOME RESEARCH (2006)
Menin regulates pancreatic islet growth by promoting histone methylation and expression of genes encoding p27Kip1 and p18INK4c
SK Karnik et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Achlorhydria, parietal cell hyperplasia, and multiple gastric carcinoids - A new disorder
SC Abraham et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2005)
The NF1 tumor suppressor critically regulates TSC2 and mTOR
CM Johannessen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours
JK Ramage et al.
GUT (2005)
Leukemia proto-oncoprotein MLL forms a SET1-like histone methyltransferase complex with menin to regulate Hox gene expression
A Yokoyama et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Pancreatic endocrine pathology in von Hippel-Linclau disease: An expanding spectrum of lesions
R Chetty et al.
ENDOCRINE PATHOLOGY (2004)
Follicle-stimulating hormone activation of hypoxia-inducible factor-1 by the phosphatidylinositol 3-kinase/AKT/Ras homolog enriched in brain (Rheb)/mammalian target of rapamycin (mTOR) pathway is necessary for induction of select protein markers of follicular differentiation
H Alam et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Randomized clinical trial of the effect of interferon α on survival in patients with disseminated midgut carcinoid tumours
L Kölby et al.
BRITISH JOURNAL OF SURGERY (2003)
Molecular basis of the VHL hereditary cancer syndrome
WG Kaelin
NATURE REVIEWS CANCER (2002)
Effect of chronic hypergastrinemia on human enterochromaffin-like cells: Insights from patients with sporadic gastrinomas
PL Peghini et al.
GASTROENTEROLOGY (2002)
Different patterns of 11q allelic losses in digestive endocrine tumors
T D'Adda et al.
HUMAN PATHOLOGY (2002)
Clear cell carcinoid tumor of the gallbladder - Another distinctive manifestation of von Hippel-Lindau disease
PA Sinkre et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2001)
Small cell carcinoma of the gallbladder - A clinicopathologic, immunohistochemical, and molecular pathology study of 12 cases
A Maitra et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2001)
Comparative genomic hybridization identifies loss of 18q22-qter as an early and specific event in tumorigenesis of midgut carcinoids
S Kytölä et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Pancreatic involvement in von Hippel-Lindau disease
PR Hammel et al.
GASTROENTEROLOGY (2000)
分享论文
